Image

Post Market Data Collection Protocol to Evaluate the Performance of the Synergy Disc

Post Market Data Collection Protocol to Evaluate the Performance of the Synergy Disc

Recruiting
21 years and older
All
Phase N/A

Powered by AI

Overview

This is a real world data collection observational study at a single site. There are both prospective and retrospective cohorts. The study will examine the safety and effectiveness of the Synergy cervical disc system in patients with degenerative cervical disc disease.

Eligibility

Inclusion Criteria:

  • Age 21 or above at the time of the surgery.
  • Have had (retrospective cohort) or the decision has been made to have (prospective cohort) the Synergy Disc implanted
  • Skeletally mature patients for reconstruction of the disc from C3-C7 following a single or multiple level discectomy for intractable radiculopathy
  • Intractable radiculopathy and/or myelopathy with at least one of the following producing symptomatic nerve root and/or spinal cord compression:
    • herniated disc and/or osteophyte formation
    • Symptomatic nerve root and/or spinal cord compression documented by patient history (arm or neck pain and/or neurologic deficit) and imaging (CT, MRI, x-rays, etc.)
    • Failed a minimum of 6 weeks conservative treatment
  • Written informed consent given by subject.

Exclusion Criteria:

  • Exclusion Criteria: All answers must be NO to be eligible for the study.
  • Moderate to advanced spondylosis
  • Diagnosis of osteoporosis
  • Active systemic infection or infection at the operative site
  • Pregnancy
  • Marked cervical instability on lateral, coronal, or flexion/extension radiographs
  • Cervical spine condition other than symptomatic cervical disc disease requiring surgical treatment at the involved level
  • Severe pathology of the facet joints of the involved vertebral bodies
  • Previous diagnosis of osteopenia or osteomalacia
  • More than one immobile vertebral level between C1 and T1 from any cause
  • Morbid obesity
  • Vulnerable person (pregnant patients, emergency cases, children, prisoners and people without mental capacity)

Study details
    Cervical Degenerative Disc Disease

NCT05880823

Synergy Spine Solutions

29 April 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.